SCHEMBL4610312

SCHEMBL4610312

CC(C)C(CS(=O)(=O)N1CCN(c2ccc(F)cc2F)CC1)C(=O)NO

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.43
KDM4E B2RXH2 2/20 0.42
CYP3A4 P08684 1/20 0.41
MMP13 P45452 1/20 0.41
MMP14 P50281 1/20 0.41
ALDH1A1 P00352 3/20 0.40
LMNA P02545 2/20 0.40
PKM P14618 1/20 0.40
GLA P06280 1/20 0.40
DPP4 P27487 1/20 0.39
DPP9 Q86TI2 1/20 0.39
NPY2R P49146 1/20 0.39
GRM5 P41594 1/20 0.39
TSHR P16473 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TP53 P04637 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
RORC P51449 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4610291 0.91 LMNA (0.44) HSD17B10CYP3A4MMP13MMP14ALDH1A1
SCHEMBL4610084 0.88 CXCR3 (0.48) HSD17B10KDM4EALDH1A1LMNASMN1; SMN2
SCHEMBL4611167 0.87 HSD17B10 (0.60) HSD17B10KDM4EALDH1A1LMNAGLA
SCHEMBL4610253 0.82 MAPT (0.49) MMP13ALDH1A1LMNASMN1; SMN2TP53
SCHEMBL4609903 0.81 SMN1; SMN2 (0.38) HSD17B10LMNAPKMDPP4DPP9
SCHEMBL6783038 0.80 MMP13 (0.42) CYP3A4MMP13MMP14LMNATP53
SCHEMBL4609998 0.80 GRM5 (0.47) HSD17B10KDM4EALDH1A1LMNAPKM
SCHEMBL6783034 0.80 MMP13 (0.42) CYP3A4MMP13MMP14LMNATP53
SCHEMBL4612472 0.79 HSD17B10 (0.49) HSD17B10KDM4EALDH1A1LMNAGLA
SCHEMBL4610349 0.79 MAPK1 (0.47) HSD17B10CYP3A4MMP13ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1641771-B1 HYDROXAMATE SULFONAMIDES AS CD23 SHEDDING INHIBITORS UCB PHARMA SA (BE) 2008-10-15 EP disclosed